Tricuspid Valve Percutaneous Therapies

Bhaskar Bhardwaj, Joaquin E. Cigarroa, Firas Zahr

Research output: Contribution to journalReview articlepeer-review


Purpose of Review: In this review, we have focused on the currently available transcatheter tricuspid valve therapies, device selection, as well as role and management of tricuspid regurgitation (TR) in the setting of other transcatheter valvular procedures. Recent Findings: In this review, we have enlisted the recently finished as well as ongoing trials in the percutaneous tricuspid valve therapies. Summary: TR is highly prevalent yet remains underrecognized and is often untreated. TR has traditionally been managed conservatively with medical therapies including diuretics for volume management, whereas surgical therapies are reserved for those undergoing left-sided valvular surgery. Although the transcatheter devices for tricuspid repair and replacement are in clinical trials, the experience to date for their effectiveness and safety has been reassuring.

Original languageEnglish (US)
Pages (from-to)1209-1226
Number of pages18
JournalCurrent cardiology reports
Issue number9
StatePublished - Sep 2022


  • Transcatheter tricuspid valve repair
  • Transcatheter tricuspid valve replacement
  • Tricuspid regurgitation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Tricuspid Valve Percutaneous Therapies'. Together they form a unique fingerprint.

Cite this